Healthcare Realty Trust (NYSE:HR – Get Free Report) released its earnings results on Wednesday. The real estate investment trust reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.01, Zacks reports. The business had revenue of $309.77 million for the quarter, compared to analyst estimates of $303.81 million. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The company’s revenue for the quarter was down 6.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.39 earnings per share. Healthcare Realty Trust updated its FY 2025 guidance to 1.560-1.600 EPS and its FY25 guidance to $1.56 to $1.60 EPS.
Healthcare Realty Trust Stock Down 0.0 %
HR stock traded down $0.01 on Friday, reaching $16.58. 396,983 shares of the company’s stock were exchanged, compared to its average volume of 2,366,098. The stock has a fifty day moving average of $16.67 and a 200-day moving average of $17.41. Healthcare Realty Trust has a twelve month low of $12.77 and a twelve month high of $18.90. The firm has a market cap of $5.87 billion, a PE ratio of -9.31 and a beta of 0.94.
Healthcare Realty Trust Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 19th. Investors of record on Monday, March 3rd will be issued a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 7.48%. The ex-dividend date of this dividend is Monday, March 3rd. Healthcare Realty Trust’s dividend payout ratio is presently -69.66%.
Insider Buying and Selling
Wall Street Analyst Weigh In
A number of research firms have recently issued reports on HR. Wedbush reissued an “outperform” rating and issued a $16.00 target price on shares of Healthcare Realty Trust in a report on Thursday. Jefferies Financial Group lowered Healthcare Realty Trust from a “buy” rating to a “hold” rating and dropped their target price for the company from $19.00 to $17.00 in a report on Thursday, January 2nd. Finally, JPMorgan Chase & Co. lowered Healthcare Realty Trust from an “overweight” rating to a “neutral” rating and set a $19.00 target price on the stock. in a report on Friday, December 20th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $17.40.
Get Our Latest Report on Healthcare Realty Trust
Healthcare Realty Trust Company Profile
Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.
Recommended Stories
- Five stocks we like better than Healthcare Realty Trust
- Using the MarketBeat Dividend Tax Calculator
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
- How to Short a Stock in 5 Easy StepsĀ
- MercadoLibre: High-Growth EM Stock With 100% Upside Potential
- Using the MarketBeat Dividend Yield Calculator
- As the Magnificent 7 Stalls, These 3 Stocks Are Gaining Momentum
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.